SA PRO
Free Account
C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating
Buy
14 analysts·Moderate coverage
71%
Rating Distribution
Strong Buy
00%
Buy
1071%
Hold
321%
Sell
17%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 248% higher.

Bear Case
$5.00
+149%
Consensus
$7.00
+248%
Bull Case
$10.00
+398%
Price Range14 analysts
Low
Consensus
High
$5.00
$10.00
Current Target
Current Price
$2.01
Upside to Target
$4.99

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 17, 2025Barclays
C4 Therapeutics price target lowered to $5 from $10 at Barclays
Target:$5.00
+121.2%from $2.26
Sep 23, 2025Wells Fargo
C4 Therapeutics price target raised to $10 from $5 at Wells Fargo
Target:$10.00
+257.1%from $2.80
Sep 22, 2025Barclays
C4 Therapeutics price target raised to $10 from $8 at Barclays
Target:$10.00
+216.5%from $3.16
Sep 16, 2025Barclays
C4 Therapeutics initiated with an Overweight at Barclays
Target:$8.00
+134.6%from $3.41
Sep 15, 2025Stephens
C4 Therapeutics upgraded to Overweight from Equal Weight at Stephens
Target:$6.00
+68.1%from $3.57
Dec 19, 2024Wells Fargo
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Target:$12.00
+178.4%from $4.31
Sep 19, 2024BMO Capital
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC)
Target:$20.00
+191.1%from $6.87
Jan 3, 2023Wells Fargo
Wells Fargo Maintains Equal-Weight on C4 Therapeutics, Lowers Price Target to $9
Target:$9.00
+42.6%from $6.31
Apr 28, 2022Credit Suisse
Credit Suisse Initiates Coverage On C4 Therapeutics with Underperform Rating, Announces Price Target of $10
Target:$10.00
+13.0%from $8.85
Apr 11, 2022Bank of America Securities
C4 Therapeutics (CCCC) Stock: $15 Price Target From BofA
Target:$15.00
+87.3%from $8.01

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance